Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years

Eur J Pediatr. 2015 Jun;174(6):843-6. doi: 10.1007/s00431-014-2468-2. Epub 2014 Dec 16.

Abstract

The aim of this study is to describe longitudinal changes in estimated glomerular filtration rate (eGFR) in a cohort of mother-to-child HIV-infected adolescents exposed to tenofovir dixoproxil fumarate (TDF) for at least 2 years. We retrospectively examined eGFR at starting TDF (T0), at 24 months (T2) and at the final assessment (T3). Twenty-nine patients were studied. The mean duration of TDF exposure was 67 months (24-123). At baseline, the mean eGFR was 152 ml/min/1.73 m(2) (105-227, SD, 33). There was a significant decrease of eGFR from a mean of 152 ml/min/1.73 m(2) (SD, 33) at T0 to 140 ml/min/1.73 m(2) (SD, 33) at T2 and 123 ml/min/1.73 m(2) (SD, 14) at T3. The decrease of eGFR was significant, with ΔGFR (T3-T0) of -29 ml/min/1.73 m(2) (SD, 30; p < 0.0001) and a mean ΔGFR per year of -6 and ml/min/1.73 m(2) (SD, 8).

Conclusion: We noted a long-term decline in eGFR in this small cohort of mother-to-child HIV-infected adolescents receiving TDF-containing cART, even if the lack of a control group and the small sample size are major limitations.

MeSH terms

  • Adolescent
  • Anti-HIV Agents / adverse effects*
  • Child
  • Female
  • Glomerular Filtration Rate / drug effects*
  • HIV Infections / drug therapy*
  • HIV Infections / transmission
  • Humans
  • Infectious Disease Transmission, Vertical*
  • Italy
  • Longitudinal Studies
  • Male
  • Retrospective Studies
  • Tenofovir / adverse effects*
  • Young Adult

Substances

  • Anti-HIV Agents
  • Tenofovir